Is AVTX or HELP more profitable?

HELP runs the higher net margin — AVTX at -170055.93% versus HELP at 329.09%.

Avalo Therapeutics, Inc. (AVTX) vs Helus Pharma Inc. (HELP)

A side-by-side comparison of Avalo Therapeutics, Inc. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AVTX

Avalo Therapeutics, Inc.

$720M

$13.69HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT

HELP

Helus Pharma Inc.

$674M

$10.88HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — AVTX vs HELP

growth of $100 · dividends reinvested · last 1y

AVTX -18.7% (-18.7%/yr)HELP +93.2% (+93.2%/yr)HELP compounded faster over this window

AVTX HELP

AVTX vs HELP: by the numbers

•AVTX is the larger company ($720M vs $674M market cap).
•HELP is profitable (329.09% net margin) while AVTX runs a net loss (-170055.93%).

Metrics side by side

Valuation

Metric	AVTX	HELP
P/S ratio	12197.00	N/A
P/B ratio	1.60	2.79

Profitability

Metric	AVTX	HELP
Gross margin	100.00%	100.27%
Operating margin	-123601.69%	317.06%
Net margin	-170055.93%	329.09%
ROE	-22.36%	-75.79%
ROIC	-19.45%	-73.27%

Growth (annualized)

Metric	AVTX	HELP
Revenue CAGR (5Y)	-60.88%	N/A
Total return CAGR (5Y)	-70.04%	N/A

Frequently asked

Is AVTX or HELP more profitable?: HELP runs the higher net margin — AVTX at -170055.93% versus HELP at 329.09%.

Go deeper

Full AVTX analysis Full HELP analysis Interactive comparison tool

Dig into the metrics

Avalo Therapeutics ROE Helus Pharma ROE Avalo Therapeutics operating margin Helus Pharma operating margin Avalo Therapeutics revenue growth Helus Pharma revenue growth Avalo Therapeutics free cash flow Helus Pharma free cash flow

Avalo Therapeutics & Helus Pharma appear in these rankings

Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.